Session 1: Reconsidering the optimization of first-line treatment strategies in locally advanced or metastatic urothelial cancer

Release date: 30-04-2024

Expiration date: 29-04-2025

Opening & Keynote Speech: First-line treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)

Enrique Grande, MD, MSc, PhD

Enrique Grande, MD, MSc, PhD

MD Anderson Cancer Center Madrid

Madrid, Spain

  • Opening & Keynote Speech: First-line treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)

    Enrique Grande, MD, MSc, PhD

  • Case 1: First-line treatment with maintenance immunotherapy for a platinum-eligible patient & Case 2: First-line treatment with mono-immunotherapy for a cisplatin-ineligible patient

    Joachim Chan, BSc, MBBS, MRCP, FRCR, MD

  • Panel Discussion & Pearls for Practice

    Fernando Maluf, MD, PhD